Search Results
Semiconductor Chip Shortage is Impacting Patient Care Globally
Baxter International Inc. (NYSE:BAX), a global medtech leader, and its suppliers have been impacted by shortages of electromechanical components, including semiconductor chips, used in many of its products. Several of the company's critical products require multiple chips per device, including infusion pumps, patient monitoring systems and continuous renal replacement therapy systems.
Baxter Issues Urgent Medical Device Recall of Clearlink Solution Set 2R8403 Due to Potential Risk of Leaking Complications
Baxter International Inc. announced today it has issued an Urgent Medical Device Recall of Clearlink Solution Set 2R8403 due to an increase in customer reports of leaks. The affected product was distributed to customers beginning on Oct. 14, 2020, in the United States.
Hope Starts at Home
Dawn is a mom and travel and shopping enthusiast. But her true passion lies in being a full-time kidney patient advocate who regularly speaks to patients about her 30-year care journey. She aims to empower others to take an active role with their healthcare team in making therapy choices, including starting on home dialysis when possible.
Baxter Reports Second-Quarter 2022 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2022.
Baxter Issues Urgent Medical Device Correction Regarding Potential Risk of Medication Error When Using Abacus Order Entry and Calculation Software
Baxter International Inc. announced today it has issued an Urgent Medical Device Correction regarding the potential risk of medication error when using certain product codes for the Abacus Order Entry and Calculation Software. The Abacus software is commonly used with ExactaMix automated compounding devices (ExactaMix 1200 and ExactaMix 2400).
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on October 3, 2022, to shareholders of record as of September 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.
Lifting Up Our Most Important Assets
Sylvie is site director of Baxter’s plant in Meyzieu, France, joining the company in 2001 as a Production Manager. She leads a team of more than 500 employees manufacturing chronic dialyzers for permanent renal failure and acute therapies in intensive care, including products used in severe cases of COVID-19. Products made in Meyzieu Save and Sustain the lives of patients in 92 countries.
Providing a Spark for a Radiant Child
Minutes after giving birth, uncertainty set in for a first-time mother. Her child was premature and in need of immediate medical attention. Waiting in the ICU was a lifeline.
What is Diabetic Retinopathy?
Diabetic retinopathy can be an invisible, yet life changing condition. That's why it is critical that people living with diabetes have annual vision screenings so that the condition can be detected before it causes vision loss.